187 related articles for article (PubMed ID: 27189602)
1. Alzheimer's Disease and Molecular Chaperones: Current Knowledge and the Future of Chaperonotherapy.
Marino Gammazza A; Bavisotto CC; Barone R; de Macario EC; Macario AJ
Curr Pharm Des; 2016; 22(26):4040-9. PubMed ID: 27189602
[TBL] [Abstract][Full Text] [Related]
2. Chaperones-A New Class of Potential Therapeutic Targets in Alzheimer's Disease.
Batko J; Antosz K; Miśków W; Pszczołowska M; Walczak K; Leszek J
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542375
[TBL] [Abstract][Full Text] [Related]
3. Chaperone signalling complexes in Alzheimer's disease.
Koren J; Jinwal UK; Lee DC; Jones JR; Shults CL; Johnson AG; Anderson LJ; Dickey CA
J Cell Mol Med; 2009 Apr; 13(4):619-30. PubMed ID: 19449461
[TBL] [Abstract][Full Text] [Related]
4. Molecular Chaperones and Thyroid Cancer.
Paladino L; Vitale AM; Santonocito R; Pitruzzella A; Cipolla C; Graceffa G; Bucchieri F; Conway de Macario E; Macario AJL; Rappa F
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919591
[TBL] [Abstract][Full Text] [Related]
5. The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases.
Lackie RE; Maciejewski A; Ostapchenko VG; Marques-Lopes J; Choy WY; Duennwald ML; Prado VF; Prado MAM
Front Neurosci; 2017; 11():254. PubMed ID: 28559789
[TBL] [Abstract][Full Text] [Related]
6. Tau phosphorylation, molecular chaperones, and ubiquitin E3 ligase: clinical relevance in Alzheimer's disease.
Kumar P; Jha NK; Jha SK; Ramani K; Ambasta RK
J Alzheimers Dis; 2015; 43(2):341-61. PubMed ID: 25096626
[TBL] [Abstract][Full Text] [Related]
7. HSP-molecular chaperones in cancer biogenesis and tumor therapy: an overview.
Rappa F; Farina F; Zummo G; David S; Campanella C; Carini F; Tomasello G; Damiani P; Cappello F; DE Macario EC; Macario AJ
Anticancer Res; 2012 Dec; 32(12):5139-50. PubMed ID: 23225410
[TBL] [Abstract][Full Text] [Related]
8. Chaperonopathies and chaperonotherapy.
Macario AJ; Conway de Macario E
FEBS Lett; 2007 Jul; 581(19):3681-8. PubMed ID: 17475257
[TBL] [Abstract][Full Text] [Related]
9. Protein misfolding, ER stress and chaperones: an approach to develop chaperone-based therapeutics for Alzheimer's disease.
Singh R; Kaur N; Dhingra N; Kaur T
Int J Neurosci; 2023 Jul; 133(7):714-734. PubMed ID: 34402740
[TBL] [Abstract][Full Text] [Related]
10. Tau Protein Squired by Molecular Chaperones During Alzheimer's Disease.
Gorantla NV; Chinnathambi S
J Mol Neurosci; 2018 Nov; 66(3):356-368. PubMed ID: 30267382
[TBL] [Abstract][Full Text] [Related]
11. Chaperonopathies by defect, excess, or mistake.
Macario AJ; Conway de Macario E
Ann N Y Acad Sci; 2007 Oct; 1113():178-91. PubMed ID: 17483209
[TBL] [Abstract][Full Text] [Related]
12. Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease.
Salminen A; Ojala J; Kaarniranta K; Hiltunen M; Soininen H
Prog Neurobiol; 2011 Jan; 93(1):99-110. PubMed ID: 21056617
[TBL] [Abstract][Full Text] [Related]
13. The Chaperone System in Breast Cancer: Roles and Therapeutic Prospects of the Molecular Chaperones Hsp27, Hsp60, Hsp70, and Hsp90.
Alberti G; Vergilio G; Paladino L; Barone R; Cappello F; Conway de Macario E; Macario AJL; Bucchieri F; Rappa F
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887137
[TBL] [Abstract][Full Text] [Related]
14. Circulating Molecular Chaperones in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease: Data from the Zabùt Aging Project.
Marino Gammazza A; Restivo V; Baschi R; Caruso Bavisotto C; Cefalù AB; Accardi G; Conway de Macario E; Macario AJL; Cappello F; Monastero R
J Alzheimers Dis; 2022; 87(1):161-172. PubMed ID: 30584145
[TBL] [Abstract][Full Text] [Related]
15. Hsp90 activator Aha1 drives production of pathological tau aggregates.
Shelton LB; Baker JD; Zheng D; Sullivan LE; Solanki PK; Webster JM; Sun Z; Sabbagh JJ; Nordhues BA; Koren J; Ghosh S; Blagg BSJ; Blair LJ; Dickey CA
Proc Natl Acad Sci U S A; 2017 Sep; 114(36):9707-9712. PubMed ID: 28827321
[TBL] [Abstract][Full Text] [Related]
16. Heat Shock Proteins in Alzheimer's Disease: Role and Targeting.
Campanella C; Pace A; Caruso Bavisotto C; Marzullo P; Marino Gammazza A; Buscemi S; Palumbo Piccionello A
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30200516
[TBL] [Abstract][Full Text] [Related]
17. The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins.
Dickey CA; Kamal A; Lundgren K; Klosak N; Bailey RM; Dunmore J; Ash P; Shoraka S; Zlatkovic J; Eckman CB; Patterson C; Dickson DW; Nahman NS; Hutton M; Burrows F; Petrucelli L
J Clin Invest; 2007 Mar; 117(3):648-58. PubMed ID: 17304350
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms in chaperonopathies: clues to understanding the histopathological abnormalities and developing novel therapies.
Macario AJ; de Macario EC
J Pathol; 2020 Jan; 250(1):9-18. PubMed ID: 31579936
[TBL] [Abstract][Full Text] [Related]
20. Updates on Aβ Processing by Hsp90, BRICHOS, and Newly Reported Distinctive Chaperones.
Iqbal M; Lewis SL; Padhye S; Jinwal UK
Biomolecules; 2023 Dec; 14(1):. PubMed ID: 38254616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
